Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.0892
Delayed Data
As of Jun 22
 -0.0033 / -3.57%
Today’s Change
0.06
Today|||52-Week Range
0.20
-3.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues5.0M12.5M9.6M7.5M
 
 
 
 
 
Cost of Goods Sold3.0M4.5M5.6M3.3M
 
 
 
 
 
Depreciation And Amortization617.0K665.6K700.4K982.2K
 
 
 
 
 
 
Operating ExpensesGross Income1.4M7.3M3.4M3.1M
 
 
 
 
 
General Expenses17.9M15.7M10.7M12.2M
 
 
 
 
 
Research And Development14.7M12.4M8.3M9.6M
 
 
 
 
 
Total Operating Expenses21.5M20.8M17.0M16.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.5M-8.3M-7.4M-9.1M
 
 
 
 
 
Extraordinary Credit44.0M7.4M9.5M4.7M
 
 
 
 
 
Interest Expense On Debt287.2K290.5K238.2K335.5K
 
 
 
 
 
Other Expenses1.7M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income28.9M-1.2M1.9M-4.7M
 
 
 
 
 
Income Taxes-3.2K-520.5K-1.9M-1.0M
 
 
 
 
 
Net Income28.9M-10.0M24.5M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS591.2M673.9M838.7M796.1M
 
 
 
 
 
Shares To Calculate EPS Diluted757.6M673.9M844.5M798.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.01-$0.01-$0.01
 
 
 
 
 
EPS Diluted-$0.02-$0.01-$0.01-$0.01